TransMedics Group, Inc. (TMDX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

40.54M
Year ended 2025-12-31
+11.1%
3-year compound annual growth
+10.4%
5-year compound annual growth
2020-12-31: 24.70M2021-12-31: 27.62M2022-12-31: 29.56M2023-12-31: 32.52M2024-12-31: 35.22M2025-12-31: 40.54M40.54M
2020-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3140.54M+15.1%2026-02-24, From 2025-01-01
2024-12-3135.22M+8.3%2026-02-24, From 2024-01-01
2023-12-3132.52M+10.0%2026-02-24, From 2023-01-01
2022-12-3129.56M+7.0%2025-02-27, From 2022-01-01
2021-12-3127.62M+11.8%2024-02-27, From 2021-01-01
2020-12-3124.70Mn/a2023-02-27, From 2019-12-29